Expertise in
3
conditions

Xiaochun Q. Zhang

No. 59 Haier Road, 
Qingdao, CN 
Expertise in
3
conditions
No. 59 Haier Road, 
Qingdao, CN 
OverviewLocationsClinical Research

Overview

Xiaochun Zhang practices in Qingdao, China. Zhang is highly rated in 3 conditions, according to our data. Their top areas of expertise are Squamous Cell Lung Carcinoma, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Cerebral Hypoxia, and Gastrectomy.

Their clinical research consists of co-authoring 110 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.

Locations

No. 59 Haier Road, Qingdao, China
Other Locations
No. 59 Haier Road, Qingdao, 266000, China
16 Jiangsu Road, Qingdao, 266000, China
No. 59 Haier Road, Qingdao, 266016, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Clinical Study Comparing the Efficacy and Safety of Tislelizumab (BGB-A317) Plus Platinum and Fluoropyrimidine Versus Placebo Plus Platinum and Fluoropyrimidine as First-Line Treatment in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Clinical Study Comparing the Efficacy and Safety of Tislelizumab (BGB-A317) Plus Platinum and Fluoropyrimidine Versus Placebo Plus Platinum and Fluoropyrimidine as First-Line Treatment in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Enrollment Status: Completed
Publish Date: February 14, 2025
Intervention Type: Drug
Study Phase: Phase 3

110 Total Publications

Mesuaferroic acid H suppresses HepG2 cell proliferation by disrupting iron homeostasis via transferrin targeting.
Mesuaferroic acid H suppresses HepG2 cell proliferation by disrupting iron homeostasis via transferrin targeting.
Journal: Bioorganic chemistry
Published: June 24, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Zhang's expertise for a condition
ConditionClose
      View All 15 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile